LSE - Delayed Quote SEK

Getinge AB (publ) (0GZV.L)

Compare
227.80
+0.26
+(0.11%)
At close: July 22 at 8:40:27 AM GMT+1

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
NameTitlePayExercisedYear Born
Mr. Mattias Perjos M.Sc. CEO, President & Director 59.84M -- 1972
Ms. Agneta Palmer Chief Financial Officer -- -- 1978
David Kordel Head of Investor Relations -- -- --
Ms. Anna Romberg MSc Econ Executive Vice President of Sustainability, Legal & Compliance -- -- 1979
Caroline Ormgard Head of Public & Media Relations -- -- --
Mr. Magnus Lundback Ph.D. Executive Vice President of Human Resources -- -- 1969
Mr. Carsten Blecker Chief Commercial Officer -- -- 1966
Mr. Stephane Le Roy President of Surgical Workflows -- -- 1977
Mr. Eric Honroth President of Life Science -- -- 1971
Ms. Patricia A. Fitch President of North America Region -- -- --

Getinge AB (publ)

Lindholmspiren 7A
P.O. Box 8861
Gothenburg, SE-417 56
Sweden
46 1 03 35 00 00 https://www.getinge.com
Full Time Employees: 
11,791

Description

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It provides extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solutions. In addition, the company offers surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, vascular and cardiothoracic surgery equipment, peripheral stenting, OEM solutions, and beating heart surgery equipment; and operating room equipment, anesthesia, advanced patient monitoring, and operating room integration solutions. Further, it provides pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices, and patient flow management; and low temperature sterilization, biocontainment in vaccine production, terminal sterilization, sterile isolation technology, cleaning and sterilization, aseptic transfer, and large-scale cultivation. Additionally, the company provides bioreactor preparation solution, bioprocess development and optimization, labware cleaning and sterilization, biocontainment, and vivarium. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

Corporate Governance

Getinge AB (publ)’s ISS Governance QualityScore as of April 1, 2025 is 9. The pillar scores are Audit: 10; Board: 9; Shareholder Rights: 8; Compensation: 2.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

April 22, 2025 at 10:00 AM UTC

Getinge AB (publ) Earnings Date

Recent Events